Bioventus Stock Performance
| BVS Stock | USD 11.71 0.20 1.74% |
On a scale of 0 to 100, Bioventus holds a performance score of 8. The firm shows a Beta (market volatility) of 0.37, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bioventus' returns are expected to increase less than the market. However, during the bear market, the loss of holding Bioventus is expected to be smaller as well. Please check Bioventus' semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Bioventus' price patterns will revert.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bioventus are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Bioventus unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.74 | Five Day Return 5.12 | Year To Date Return 123.05 | Ten Year Return (39.04) | All Time Return (39.04) |
1 | Disposition of 8886 shares by Dadamio Anthony of Bioventus subject to Rule 16b-3 | 09/06/2024 |
2 | Bioventus Surges 103 percent in Six Months Is the Stock Worth a Buy | 09/19/2024 |
3 | Bioventus Inc Shares Down 3.06 percent on Oct 7 | 10/07/2024 |
4 | Bravura Solutions Limited Insider Damien Leonard Purchases 442,921 Shares | 10/10/2024 |
5 | Bioventus Surges 73 percent in Three Months Time to Buy the Stock | 10/22/2024 |
6 | Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024 | 10/29/2024 |
7 | Bioventus Inc Q3 2024 Earnings Report Preview What To Look For | 11/04/2024 |
8 | Bioventus Reports Third Quarter Financial Results | 11/05/2024 |
9 | Bioventus Inc. Q3 2024 Earnings Call Transcript | 11/07/2024 |
10 | Royce Associates LP Invests 8.34 Million in Bioventus Inc. - MarketBeat | 11/18/2024 |
| Begin Period Cash Flow | 31.8 M |
Bioventus |
Bioventus Relative Risk vs. Return Landscape
If you would invest 966.00 in Bioventus on August 27, 2024 and sell it today you would earn a total of 205.00 from holding Bioventus or generate 21.22% return on investment over 90 days. Bioventus is generating 0.3663% of daily returns assuming volatility of 3.5832% on return distribution over 90 days investment horizon. In other words, 31% of stocks are less volatile than Bioventus, and above 93% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Bioventus Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioventus' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bioventus, and traders can use it to determine the average amount a Bioventus' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1022
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BVS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.58 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.37 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 8 92% of assets perform better |
Based on monthly moving average Bioventus is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bioventus by adding it to a well-diversified portfolio.
Bioventus Fundamentals Growth
Bioventus Stock prices reflect investors' perceptions of the future prospects and financial health of Bioventus, and Bioventus fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bioventus Stock performance.
| Return On Equity | -0.25 | ||||
| Return On Asset | 0.0248 | ||||
| Profit Margin | (0.07) % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 1.11 B | ||||
| Shares Outstanding | 65.37 M | ||||
| Price To Earning | 6.96 X | ||||
| Price To Book | 5.15 X | ||||
| Price To Sales | 1.38 X | ||||
| Revenue | 512.35 M | ||||
| Gross Profit | 302.71 M | ||||
| EBITDA | (23.07 M) | ||||
| Net Income | (96.74 M) | ||||
| Cash And Equivalents | 34.36 M | ||||
| Cash Per Share | 0.56 X | ||||
| Total Debt | 394.85 M | ||||
| Debt To Equity | 1.17 % | ||||
| Current Ratio | 0.94 X | ||||
| Book Value Per Share | 2.28 X | ||||
| Cash Flow From Operations | 15.34 M | ||||
| Earnings Per Share | (0.61) X | ||||
| Market Capitalization | 765.46 M | ||||
| Total Asset | 810.91 M | ||||
| Retained Earnings | (321.54 M) | ||||
| Working Capital | 92.5 M | ||||
About Bioventus Performance
Assessing Bioventus' fundamental ratios provides investors with valuable insights into Bioventus' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Bioventus is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 181.03 | 118.18 | |
| Return On Tangible Assets | (0.49) | (0.46) | |
| Return On Capital Employed | (0.13) | (0.12) | |
| Return On Assets | (0.19) | (0.18) | |
| Return On Equity | (0.90) | (0.85) |
Things to note about Bioventus performance evaluation
Checking the ongoing alerts about Bioventus for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bioventus help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bioventus had very high historical volatility over the last 90 days | |
| Bioventus has high likelihood to experience some financial distress in the next 2 years | |
| Bioventus has 394.85 M in debt with debt to equity (D/E) ratio of 1.17, which is OK given its current industry classification. Bioventus has a current ratio of 0.92, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Bioventus to invest in growth at high rates of return. | |
| The entity reported the last year's revenue of 512.35 M. Reported Net Loss for the year was (96.74 M) with profit before taxes, overhead, and interest of 302.71 M. | |
| About 70.0% of Bioventus shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Royce Associates LP Invests 8.34 Million in Bioventus Inc. - MarketBeat |
- Analyzing Bioventus' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bioventus' stock is overvalued or undervalued compared to its peers.
- Examining Bioventus' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bioventus' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bioventus' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bioventus' stock. These opinions can provide insight into Bioventus' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Bioventus Stock Analysis
When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.